home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Software Vault: The Diamond Collection
/
The Diamond Collection (Software Vault)(Digital Impact).ISO
/
cdr16
/
med9505d.zip
/
M9550868.TXT
< prev
next >
Wrap
Text File
|
1995-03-25
|
2KB
|
38 lines
Document 0868
DOCN M9550868
TI Effect of the combination of interferon-alpha and stavudine on Friend
virus infections in (B10.A x A.By)F1 mice.
DT 9505
AU Sidwell RW; Warren RP; Okleberry K; Burger RA; Morrey JD; Department of
Animal, Dairy and Veterinary Sciences, Utah State; University, Logan
84322-5600.
SO J Infect Dis. 1995 Mar;171 Suppl 2:S93-8. Unique Identifier : AIDSLINE
MED/95164995
AB The anti-Friend leukemia virus (FLV) effects of interferon-alpha-A/D
(IFN-alpha) and 2',3'-didehydro-2',3'-dideoxythymidine (stavudine) used
alone and in combination were examined in Mus dunni cells using a
checkerboard-type experiment design. Strong antiviral synergy and a
suggested cytotoxic synergy were seen. In two experiments to evaluate
the effect of combining therapy with IFN-alpha and stavudine against FLV
disease in the hybrid mouse strain (B10.A x A.By)F1, which is a strong
producer of cytotoxic T cells, the drug combination resulted in better
inhibition of FLV disease than did either drug used alone. Combination
therapy inhibited splenomegaly, splenic virus infectious centers, plasma
virus, and the virus-induced increase in hematocrit to a greater degree
than did either drug alone. These data indicate that combination therapy
with stavudine and IFN-alpha is effective in the treatment of murine
retrovirus infections and may be of value in the treatment of human
AIDS.
DE Acquired Immunodeficiency Syndrome/DRUG THERAPY Animal Cells, Cultured
Cytotoxicity, Immunologic/DRUG EFFECTS Drug Synergism Drug Therapy,
Combination Female *Friend Virus/DRUG EFFECTS
Interferon-alpha/ADMINISTRATION & DOSAGE/PHARMACOLOGY/ *THERAPEUTIC USE
Leukemia, Experimental/*DRUG THERAPY Male Mice Mice, Inbred Strains
Retroviridae Infections/*DRUG THERAPY Stavudine/ADMINISTRATION &
DOSAGE/PHARMACOLOGY/*THERAPEUTIC USE Support, U.S. Gov't, P.H.S. Tumor
Virus Infections/*DRUG THERAPY JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).